Amprol 9.6% Solution (Canada)

(amprolium)

FOR VETERINARY USE ONLY

09568A(CA)

DIN 00140481

Active Ingredient

Each mL contains 96 mg of amprolium

Warning

Calves - Treated animals must not be slaughtered for use in food for at least 7 days after the latest treatment with this drug.

Amprol 9.6% Solution Indications

POULTRY - As an aid in the treatment of caecal coccidiosis in growing chickens and laying birds.

CALVES - As an aid in the treatment of coccidiosis caused by Eimeria bovis and E. zuernii in calves.

Use Directions

POULTRY - As soon as caecal coccidiosis is diagnosed, give 0.024% amprolium in the drinking water for 5 to 7 days. Continue treatment with 0.006% amprolium medicated water for an additional one to two weeks.

No other source of drinking water should be available to the birds during this time.

Use as the sole source of amprolium.

CALVES - 0.012% amprolium in drinking water for 5 days. At the usual rate of water consumption, this will provide a daily intake of approximately 10 mg of amprolium per kg of body weight. Give as the sole source of water during the treatment period.

NOTE - When one or more calves show signs of coccidiosis, it is likely that the rest of the group have been exposed, and all calves in the group should be treated.

Mixing Directions

To prepare 200 L of medicated water:

Amprol 9.6% Solution Caution

1. POULTRY - If no improvement is noted within 3 days, have the diagnosis reconfirmed and follow the instructions of your veterinarian or poultry pathologist. Losses may result from intercurrent disease or other conditions affecting drug intake which can contribute to the virulence of coccidiosis under field conditions.

2. CALVES - For a satisfactory diagnosis, a microscopic examination of the feces should be done before treatment. When treating outbreaks, drug should be administered promptly after diagnosis is determined.

Do not use in calves intended for future breeding.

Storage

Protect from freezing. Keep above 5°C.

^® Trademark HUVEPHARMA EOOD

Distributed by: Huvepharma Canada Corporation Inc., 275 Slater Street, suite 900, Ottawa, Ontario K1P 5H9

HUVEPHARMA EOOD, 5th Floor, 3 “A”, Nikolay Haytov Str., Sofia 1113, Bulgaria

CPN: 1299005.2